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Abstract
Background Haemorrhoidal disease (HD) is a common colorectal condition that often requires surgical treatment. Less 
invasive procedures are usually more acceptable to patients. The aim of this study was to report the outcome of a novel and 
minimally invasive technique employing a radiofrequency ablation (RFA) energy  (Rafaelo®) to treat HD.
Methods A total number of 27 patients who had RFA for the treatment of HD were recruited to this study. The procedure 
was performed under deep sedation and local anaesthesia. Patients’ demographics; haemorrhoid severity score (HSS); quality 
of life; pain and satisfaction scores; and recurrence rate were recorded.
Results The mean age of the patients was 46 (SD 14) years, 18 (67%) males and 9 (33%) females. The mean body mass 
index was 25 (SD 4) kg/m2. The predominant symptom of all patients was per-rectal bleeding. HSS improved from 7.2 (SD 
1.9) before the procedure to 1.6 (SD 1) after the procedure (p < 0.0001). Postoperative pain scores on a scale of 0–10 were 
0, 2 (SD 2), 1 (SD 2), and 0 on immediate, day-1, day-3, and 2-month follow-up questionnaire. The mean satisfacion score 
was 9 (SD 1.5) out of 10 on 2-month follow-up. Mean time until patients returned to normal daily activity was 3 (SD 1) 
days following the procedure. Quality-of-life assessments including: visual analogue scale scores (before: mean 70, SD 23; 
after: mean 82, SD 16; p < 0.001) and EQ-5D-5L (before: mean 0.84, SD 0.15; after: mean 0.94, SD 0.13; p < 0.05) were 
significantly improved. The mean length of follow-up for recurrence of symptoms was 20 months (range 12–32 months). 
One patient (4%) reported the recurrence of rectal bleeding 12 months after the procedure.
Conclusions RFA for the treatment of HD is safe and effective in achieving symptomatic relief. It is associated with minimal 
postoperative pain and low incidence of recurrence.
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Introduction
Pathological enlargement and displacement of the anal vas-
cular cushions referred to as haemorrhoidal disease (HD) 
may be associated with pain, itching, bleeding, discharge 
(soiling), and haemorrhoidal tissue prolapse [1]. Although 
the true prevalence is unknown due to many patients being 
too embarrassed to seek treatment, a significant number of 
people around the world pursue medical and surgical treat-
ment. Thus, HD is both a medical problem and a socioeco-
nomic burden [2].
In patients who have persisting symptoms despite con-
servative treatment, there are several surgical options avail-
able. While excisional haemorrhoidectomy is considered to 
be the most effective treatment, significant postoperative 
pain and changes in the anatomy of the anal canal can impair 
defecation. This has led surgeons to adopt more tolerable 
procedures, such as stapled haemorrhoidectomy, haemor-
rhoidal artery ligation, haemorrhoidal dearterialisation, rub-
ber banding ligation, infrared coagulation, and sclerotherapy 
or phenol injection. Yet, no single technique has been uni-
versally accepted as the best treatment [3]. The therapeutic 
choice of treatment is largely dependent on the severity of 
the symptoms, size of haemorrhoidal tissue, and extent of 
displacement. For example, HD with severe prolapsing skin 
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that makes it difficult for the patient to maintain hygiene 
may require excision. However, patients’ preference tends 
to gravitate towards less invasive procedures.
Radiofrequency ablation (RFA) utilises an electrical cur-
rent produced by radio waves to generate heat. For many 
years, this method has been used to ablate dysfunctional 
tissue in benign and malignant disease [4]. Akin to sclero-
therapy, rubber banding, and infrared coagulation, RFA for 
early stage HD has shown promising results [5]. It causes 
obliteration of vascular channels, fibrosis, and shrinkage of 
the anorectal cushions. Long term, these changes can lead to 
plication of anorectal mucosa and alleviation of symptoms. 
The effect of RFA on tissue has been reported previously in 
vein and tumour ablation [6]. Histologically, tissues demon-
strated significant uniform collagen contraction and fibro-
sis [7, 8]. For the first time, RFA for HD has been offered 
to National Health Service (NHS) patients in the United 
Kingdom by University College London Hospital NHS trust 
(UCLH). The aim of the present study was to evaluate the 
outcomes of RFA for the treatment of HD.
Materials and methods
A total number of 27 patients had RFA for HD and were 
included in a pilot study at UCLH, between the period Feb-
ruary 2016 and October 2018. The procedure was approved 
by the Trust’s Clinical Effectiveness Steering Committee. 
Data collection and analysis was approved as service evalu-
ation by our audit department. Recruitment of patients was 
conducted in the colorectal outpatient clinic. Inclusion cri-
teria were as follows: patients with symptomatic HD; grade 
II–IV HD; age between 18 and 80 years; and ability to give 
written consent for the procedure and the study. Those who 
required concomitant interventions for other perianal condi-
tions, such as anal fissure or skin tag excision, were excluded 
from the analysis. Patients were warned about the possibility 
of surgical bleeding, failure and pain post operatively as with 
all haemorrhoidal procedures.
Face-to-face and telephone interviews were conducted 
pre- and postoperatively by the direct care team to collect 
data on patient demographics; diagnostics; postoperative 
pain and satisfaction scores; and procedure-related compli-
cations. We also gave patients a questionnaire to assess their 
Haemorrhoid Severity Score (HSS), including pain, itch-
ing, discomfort, bleeding, soiling, and haemorrhoidal tissue 
prolapse [9, 10] (Table 1); anal incontinence and quality of 
life 2–3 weeks before and 6–8 weeks after the procedure. 
Cleveland Incontinence Score (CIS), European Quality-of-
Life Five Dimension, Five Level (EQ-5D-5L), and Visual 
Analogue Scale (VAS) scores were assessed before and 
2 months after the procedure. Patients were asked to rate 
their quality of life in relation to suffering from haemor-
rhoidal symptoms on a VAS ranging from 0 to 100, (0 being 
worst and 100 being the best quality of life).
CIS is widely accepted because it fulfills the criteria of 
being simple and accurate. It permits objective comparison 
of levels of incontinence among patients. It assesses incon-
tinence for solids, liquid, gas, and also whether the patients 
wear pads or suffer alterations to their quality of life as a 
result of their anal incontinence [11].
VAS is a scale, where patients are asked to indicate by 
drawing a line of their overall health at the time of assess-
ment. It usually offers complementary information to EQ-
5D-5L [12]. Furthermore, EQ-5D-5L reports information 
on five dimensions of patient’s life including: mobility; 
self-care; usual activities; pain/discomfort; and anxiety/
depression.
Surgical technique
The procedure was performed under deep sedation, or light 
general anaesthesia with the patient positioned in lithotomy. 
Perianal block was performed using approximately 40 ml 
of bupivacaine 0.25%. We used a 69 × 23 mm proctoscope 
with 100 mm-long handle and a high intensity LED light 
source (Fcaresystems, Antwerpen, Belgium). The procto-
scope has a simple vent on one side, through which a single 
haemorrhoidal tissue protrudes, while the rest of the anorec-
tal cushion is compressed. At a level approximately 5 mm 
above the dentate line, the submucosa of haemorrhoidal tis-
sue was infiltrated with approximately 1 ml of bupivacaine 
Table 1  Haemorrhoid severity 
score questionnaire
The score was graded as: 0, never; 1, less than once a week; 2, 1–6 times weekly; and 3, every day 
(always). The maximum score was 15 points. Statistical analysis was performed using paired t test before 
and after the procedure
Question 0 1 2 3
How often do you have pain from the haemorrhoid? □ □ □ □
How often do you have itching or discomfort of the anus? □ □ □ □
How often do you have bleeding when passing motion? □ □ □ □
How often do you soil your underclothes (soiling from the anus)? □ □ □ □
How often do you reduce a prolapsing haemorrhoid with your hand 
when passing a motion?
□ □ □ □
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0.25%. In addition to achieving local anaesthesia, this step 
aimed to create a fluid barrier and subsequently prevent the 
transmission of heat to the internal anal sphincter muscle. 
The  Rafaelo® device and associated HPR45i probe (Fcar-
esystems, Antwerpen, Belgium) were used to deploy RFA 
energy of 4 MHz frequency to the haemorrhoidal tissue. 
The tip of the probe was inserted fully into the haemor-
rhoid tissue approximately to a depth of 5–10 mm, at an 
approximately 30° angle to the tissue surface (Fig. 1a, b). 
The haemorrhoidal tissue was tilted away from the submu-
cosal layer (Fig. 1c). The application of RFA was continued 
until the tissue exhibited whitish discolouration, after which 
the energy was applied to the external surface of the haemor-
rhoidal tissue to optimise tissue desiccation (Fig. 1d, e). A 
maximum of 3000 MHz with a power sitting of 25 W was 
applied to an individual haemorrhoidal tissue at one time. A 
cold saline soaked tonsillar swab was immediately applied 
to the surface of the haemorrhoidal tissue. Any bleeding 
was controlled by inducing coagulation using the radiofre-
quency probe. Patients were discharged on routine analgesia 
including: paracetamol, codeine, and ibuprofen to take when 
required.
Statistical analysis
Data were analysed using GraphPad Prism (GraphPad 
Prism version 6 for MAC OS X, GraphPad Software, San 
Diego California USA). For inference statistics, paired t 
test was used to analyse continuous data and Chi-square 
test was used to analyse categorical data. The level of sta-
tistical significance was set at 5% (p ≤ 0.05) for all test 
procedures. EQ-5D-5L Crosswalk Index Value Calculator 
was used to calculate the crosswalk index values for the 
EQ-5D-5L dimension scores (EQ-5D, Rotterdam Nether-
lands, http://www.euroq ol.org).
Results
Patient characteristics are summarised in Table 2.
Procedure
The number of haemorrhoids treated at one time was 
1, 2, and 3 in 9 (33%), 15 (56%), and 3 (11%) patients, 
respectively. The median energy applied per haemorrhoid 
Fig. 1  HPR45i probe (a) is inserted into the haemorrhoidal tissue (b), tissue is tilted away from the submucosa (c), and the radiofrequency 
energy is applied until the tissue exhibits whitish discoloration (d, e)
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was 1025 J (range 50–3050 J). The median time spent 
per haemorrhoid treatment was 35 s (range 15–120 s). 
The median duration of the procedure was 10 min (range 
5–19 min.
Outcome
Haemorrhoid Severity Score
The severity of haemorrhoidal symptoms was assessed 
2–3 weeks before and 6–8 weeks after the procedure. A 
score ranging from 0 to 15 was calculated. The mean score 
of HSS was improved from 7.2 (SD 1.9) before to 1.6 (SD 
1) after the procedure (p < 0.0001) (Fig. 2A). The individual 
symptom scores and significance in difference before and 
after the procedure are summarised in Table 3.
Postoperative pain
Postoperative pain scores (VAS 0–10) were 0, 2.4 (SD 2.3), 
1.8 (SD 2.4), and 0 on immediate, day-1, day-3, and 2-month 
follow-up. Routine analgesia was used in 16 (60%), and 11 
(40%) of the patients on postoperative days 1 and 2, respec-
tively. None of the patients used analgesia in relation to their 
treated HD when reviewed at 8 weeks.
Patient satisfaction and fitness to return to normal daily 
activities
The mean satisfaction score was 9/10 (SD 1.5) at 2-month 
follow-up. The majority of patients (25, 93%) would recom-
mend the procedure to other patients and found it reliable 
and effective. Although patients were given an official doc-
tor’s notice to be off work for 10 days postoperatively, they 
reported that they felt able to return to their normal daily 
activities, including work, after a mean time of 3 days (SD 
1).
Recurrence of symptoms
There was 1 patient who reported recurrence of per-rectal 
bleeding at 12-month follow-up. This patient originally had 
three haemorrhoids, all treated at the same time. In all other 
patients, a median follow-up period of 20 months (range 
12–32 months) confirmed that there was no recurrence of 
symptoms, such as bleeding, pain, discharge, or itchiness. 
Table 2  Patient characteristics (n = 27)
ASA American Society of Anaesthesiologists, BMI body mass index, 
SD standard deviation
Age, years: mean (SD) 46 (14)
Sex
 Male 18 (67%)
 Female 9 (33%)
BMI: mean (SD) 25 (4)
ASA score
 I 18 (67%)
 II 9 (33%)
Smoker
 Yes 8 (30%)
 No 19 (70%)
Racial origin
 African 3 (11%)
 Asian 3 (11%)
 Caucasian 14 (52%)
 Middle Eastern 5 (19%)
 Mixed 2 (7%)
Haemorrhoidal severity
 Grade 2 8 (30%)
 Grade 3 10 (37%)
 Grade 4 9 (33%)
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Fig. 2  Haemorrhoidal disease severity and quality of life was 
assessed 2–3 weeks before and 6–8 weeks after the procedure. Haem-
orrhoidal Severity Score (A); Visual Analogue Score on a scale of 
0–100 quality of life in relation to haemorrhoidal disease (B); and 
EQ-5D-5L crosswalk index values (C) were significantly improved 
comparison before and after the procedure. p < 0.05 (*). p < 0.01 (**). 
p < 0.0001 (****)
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In terms of early complications, approximately 7 days fol-
lowing the initial procedure, 2 (8%) patients presented to 
the emergency department with per-rectal bleeding; this 
was minimal, and both were discharged from the emergency 
department with reassurance. There were no serious com-
plications recorded.
Cleveland Incontinence Score
A total number of 18 patients recorded their CIS score 
immediately before and 2 months after the procedure. 
Three of them reported a score of 2, 3, and 4 before the 
procedure. Subsequently, these three patients reported a 0 
CIS score after the procedure. A female patient reported 
a CIS score of 9 before and after the procedure. All 
other patients reported 0 CIS score before and after the 
procedure.
Quality‑of‑life assessment
A total number of 17 (63%) patients recorded their VAS and 
completed the EQ-5D-5L questionnaire immediately before 
and 2 months after the procedure. There was a significant 
(p < 0.001) improvement in the VAS score after the proce-
dure (mean 82, SD 16) in comparison with before (mean 
70, SD 23) (Fig. 2), 4 (23%) out of those who recorded their 
VAS score recorded a post procedure score of 100. Further-
more, EQ-5D-5L crosswalk index values were significantly 
higher (p < 0.05) after the procedure (mean 0.94, SD 0.13) 
in comparison with before (mean 0.84, SD 0.15).
Discussion
Our main findings demonstrate that RFA for HD is asso-
ciated with: minimal pain; improvement in HSS within 
6–8 weeks of the procedure and patients’ quality of life; 
and an early return to work/normal activities. There were 
no serious complications nor evidence of damage to the anal 
sphincters. Recurrence after a mean follow-up of 20 months 
was observed in only 1 (4%) of the patients, in the form 
of recurrence of bleeding. These results are consistent with 
what was reported by Gupta and colleagues, who were the 
first to report patient outcomes after RFA for haemorrhoids 
[13, 14]. Gupta et al. also compared RFA to rubber band 
ligation for the treatment of grade 2 HD. RFA group was 
associated with less pain and a lower recurrence rate. How-
ever, the incidence of bleeding and prolapsing of haemor-
rhoids were comparatively higher [13]. Furthermore, the 
return to normal activities was significantly lower in the 
RFA group (mean 2 days) in comparison with rubber band 
ligation treatment (mean 5 days) [13]. Our cohort is dif-
ferent from those in the literature, because RFA was also 
offered to patients with grade 3 and 4 HD. Previously, RFA 
was only offered to patients with grade 1 and 2 HD [15]. In 
fact, 37% and 33% of our cohort suffered from grade 3 and 
4 HD, respectively. Our rational for offering the procedure 
to patient with grade 3–4 haemorrhoids is to test its benefit 
for symptomatic relief of pain, itchiness, bleeding, or soil-
ing. In particular, for grades 3 and 4 haemorrhoids, we did 
not expect the procedure to resolve chronic skin prolapse; 
however, RFA appears to be effective in resolving other 
symptoms. So far, based on our experience, we suggest that 
the procedure could be offered for all symptomatic HD as a 
first line. However, we would still advise caution and careful 
counselling of patients with mainly external haemorrhoids 
or substantial prolapsing haemorrhoids, where excision may 
be more effective.
Although we did not perform a cost-effective analysis, the 
estimated cost per patient was £300 British Pounds (GBP) 
for the HPR45i probe and the treatment packs (single use 
disposable). However, the  Rafaelo® EVRF machine (F Care 
Systems, Antwerpen, Belgium) was loaned to the hospital 
free of charge.
The strengths of this study may be the inclusion of all 
grades of HD; that we followed patients prospectively and 
assessed the patient’s severity of symptoms, anal inconti-
nence, and quality of life before and after treatment. A mem-
ber of the direct care team interviewed the patients to collect 
the data, ensuring objectivity.
This study has several limitations. There is an inher-
ent selection and reporting bias and lack of a comparable 
group. Furthermore, our sample size is small, and we are 
not sure whether the improvement in VAS and EQ-5D-5L 
Table 3  Haemorrhoid severity score, summary of individual symp-
tom results before and after the procedure
Paired comparison was performed
a For each symptom, the minimum score was 0 (never) and the maxi-
mum score was 3 (always)
Symptoma Before: mean (SD) After: mean (SD) Significance
Pain 1.7 (0.6) 0.2 (0.1) p < 0.0001
Itching 0.9 (0.6) 0.03 (0.1) p < 0.0001
Bleeding 3 (0.2) 0.8 (0.4) p < 0.0001
Soiling 0.2 (0.3) 0 p = 0.02
Haemorrhoi-
dal tissue 
prolapse
1.3 (0.2) 0.5 (0.5) p < 0.0001
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is clinically important, although it was statistically signifi-
cant. Indeed, VAS improved to 100 only in 4 patients (23% 
of the patients who completed the assessment). This might 
be explained by the inclusion of more severe HD, where 
6–8 weeks after the procedure residual symptoms were 
observed. However, long-term resolution of symptoms after 
an average follow-up of 20 months was more promising. One 
patient (4%) confirmed the recurrence of bleeding. Thus, 
it is possible that RFA treatment offers a good long-term 
therapeutic benefit.
Conclusions
RFA for HD is safe, reliable, easy to perform, and is associ-
ated with minimal pain and an early return to work/normal 
activities. Furthermore, we have not seen evidence of func-
tional deterioration or anal incontinence following RFA, but 
rather significant improvement in patients’ quality of life. 
Further research to compare RFA to other HD treatment 
modalities in a randomised controlled trial is the next step 
to assess the effectiveness and long-term reliability of this 
procedure.
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